发明授权
- 专利标题： Triazole compounds that modulate Hsp90 activity
- 专利标题（中）： 调节Hsp90活性的三唑化合物
-
申请号： US11282119申请日： 2005-11-17
-
公开(公告)号： US07825148B2公开(公告)日： 2010-11-02
- 发明人: Weiwen Ying , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
- 申请人： Weiwen Ying , David James , Shijie Zhang , Teresa Przewloka , Junghyun Chae , Dinesh U. Chimmanamada , Chi-Wan Lee , Elena Kostik , Howard P. Ng , Kevin Foley , Zhenjian Du , James Barsoum
- 申请人地址： US MA Lexington
- 专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人： Synta Pharmaceuticals Corp.
- 当前专利权人地址： US MA Lexington
- 代理机构： Foley & Lardner LLP
- 代理商 Steven G. Davis
- 主分类号： A61K31/41
- IPC分类号： A61K31/41 ; C07D249/04
摘要：
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of Hsp90 in a subject in need thereof and methods for preventing or treating hyperproliferative disorders, such as cancer, in a subject in need thereof comprising administering to the subject a substituted triazole compound of the invention, or a composition comprising such a compound.
公开/授权文献
- US20060167070A1 Triazole compounds that modulate Hsp90 activity 公开/授权日：2006-07-27
信息查询
